These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2722598)

  • 1. Phase I/II study of Fluosol-DA and 100% oxygen as an adjuvant to radiation in the treatment of advanced squamous cell tumors of the head and neck.
    Lustig R; McIntosh-Lowe N; Rose C; Haas J; Krasnow S; Spaulding M; Prosnitz L
    Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1587-93. PubMed ID: 2722598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluosol and oxygen breathing as an adjuvant to radiation therapy in the treatment of locally advanced non-small cell carcinoma of the lung: results of a phase I/II study.
    Lustig R; Lowe N; Prosnitz L; Spaulding M; Cohen M; Stitt J; Brannon R
    Int J Radiat Oncol Biol Phys; 1990 Jul; 19(1):97-102. PubMed ID: 2166021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical trial of Fluosol DA 20% in advanced squamous cell carcinoma of the head and neck.
    Rose C; Lustig R; McIntosh N; Teicher B
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1325-7. PubMed ID: 3759553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluosol DA and oxygen as an adjuvant to the radiotherapeutic management of advanced head/neck carcinoma.
    Lustig RA; Rose CM; McIntosh-Lowe NL
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):511-8. PubMed ID: 3179488
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment-related toxicities with Fluosol-DA 20% infusion during radiation in advanced head and neck malignancies.
    Campbell BH; Janjan NA; Byhardt RW; Toohill RJ
    Laryngoscope; 1990 Mar; 100(3):237-9. PubMed ID: 2407916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I/II study of the use of Fluosol as an adjuvant to radiation therapy in the treatment of primary high-grade brain tumors.
    Evans RG; Kimler BF; Morantz RA; Vats TS; Gemer LS; Liston V; Lowe N
    Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):415-20. PubMed ID: 2168356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of complications in long-term survivors after treatment with Fluosol and oxygen as an adjuvant to radiation therapy for high-grade brain tumors.
    Evans RG; Kimler BF; Morantz RA; Batnitzky S
    Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):649-52. PubMed ID: 8330996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Fluosol-DA on the response of intracranial 9L tumors to X rays and BCNU.
    Teicher BA; Herman TS; Rose CM
    Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1187-92. PubMed ID: 3141321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of infused Fluosol-DA/carbogen with ephedrine, flunarizine, or nitroprusside.
    Teicher BA; Holden SA; Northey D; Dewhirst MW; Herman TS
    Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):103-9. PubMed ID: 8482616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactions of tumors and normal tissues in mice to irradiation in the presence and absence of a perfluorochemical emulsion.
    Rockwell S; Mate TP; Irvin CG; Nierenburg M
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1315-8. PubMed ID: 3093416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboplatin (CBDCA) and radiotherapy for stage IV carcinoma of the head and neck: a phase I-II study.
    Jacobs MC; Eisenberger M; Oh MC; Sinibaldi V; Gray W; Elias G; Salazar OM
    Int J Radiat Oncol Biol Phys; 1989 Aug; 17(2):361-3. PubMed ID: 2666366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Present status of clinical studies of Fluosol-DA (20%) in Japan.
    Mitsuno T; Ohyanagi H
    Int Anesthesiol Clin; 1985; 23(1):169-84. PubMed ID: 3980104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dose and scheduling on growth delay of the Lewis lung carcinoma produced by the perfluorochemical emulsion, Fluosol-DA.
    Teicher BA; Rose CM
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1311-3. PubMed ID: 3093415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a perfluorochemical whole blood substitute (Fluosol-DA, 20%)--an overview of clinical studies with 185 patients.
    Suyama T; Yokoyama K; Naito R
    Prog Clin Biol Res; 1981; 55():609-28. PubMed ID: 7027272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of two dosages and schedules of ifosfamide in combination with cisplatin in neo-adjuvant chemotherapy of patients with advanced (stage III-IV) head and neck squamous cell carcinoma: a phase II randomized study.
    Mantovani G; Ghiani M; Lai P; Maccio A; Dessi D; Succu G; Massa D; Curreli L; Mulas C; Esu S; Proto E; Cadeddu G; Tore G
    Oncol Rep; 1998; 5(6):1499-505. PubMed ID: 9769395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I/II trial of twice daily irradiation and concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neck.
    Brizel DM; Leopold KA; Fisher SR; Panella TJ; Fine RL; Bedrosian CL; Kenan PD; Huang A; Womack T; Bjurstrom T
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):213-20. PubMed ID: 8270444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical studies of a perfluorochemical emulsion as an adjunct to radiotherapy.
    Rockwell S; Irvin CG; Kelley M
    Int J Radiat Oncol Biol Phys; 1988 Oct; 15(4):913-20. PubMed ID: 3141320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience.
    Robbins KT; Kumar P; Regine WF; Wong FS; Weir AB; Flick P; Kun LE; Palmer R; Murry T; Fontanesi J; Ferguson R; Thomas R; Hartsell W; Paig CU; Salazar G; Norfleet L; Hanchett CB; Harrington V; Niell HB
    Int J Radiat Oncol Biol Phys; 1997 May; 38(2):263-71. PubMed ID: 9226312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent use of a perfluorochemical emulsion (Fluosol-DA 20%) and carbogen breathing with fractionated irradiation.
    Moulder JE; Fish BL
    Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1193-6. PubMed ID: 3141322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.